Operating Income Summary of Grifols, S.A.

Grifols, S.A.'s latest annual operating income in 2023 was 799.39 Million EUR , down -8.41% from previous year.
Grifols, S.A.'s latest quarterly operating income in 2024 Q1 was 241.91 Million EUR , up 8.46% from previous quarter.
Grifols, S.A. reported an annual operating income of 805.68 Million EUR in 2022, up 35.39% from previous year.
Grifols, S.A. reported an annual operating income of 595.06 Million EUR in 2021, down -40.26% from previous year.
Grifols, S.A. reported a quarterly operating income of 252.41 Million EUR for 2024 Q2, up 4.34% from previous quarter.
Grifols, S.A. reported a quarterly operating income of 253.64 Million EUR for 2023 Q2, up 57.31% from previous quarter.

Annual Operating Income Chart of Grifols, S.A. (2023 - 2005)

Historical Annual Operating Income of Grifols, S.A. (2023 - 2005)

Year	Operating Income	Operating Income Growth
2023	799.39 Million EUR	-8.41%
2022	805.68 Million EUR	35.39%
2021	595.06 Million EUR	-40.26%
2020	996.13 Million EUR	-11.95%
2019	1.13 Billion EUR	13.81%
2018	994.12 Million EUR	-0.92%
2017	1 Billion EUR	6.81%
2016	939.4 Million EUR	-3.19%
2015	970.37 Million EUR	13.14%
2014	857.68 Million EUR	16.51%
2013	736.12 Million EUR	11.52%
2012	660.08 Million EUR	136.71%
2011	278.86 Million EUR	32.99%
2010	209.68 Million EUR	-7.44%
2009	226.52 Million EUR	11.61%
2008	202.96 Million EUR	38.68%
2007	146.35 Million EUR	45.64%
2006	100.49 Million EUR	36.56%
2005	73.58 Million EUR	0.0%

Year	Operating Income	Operating Income Growth
2024 Q1	241.91 Million EUR	8.46%
2024 Q2	252.41 Million EUR	4.34%
2023 Q2	253.64 Million EUR	57.31%
2023 Q3	250.58 Million EUR	-1.21%
2023 FY	737.91 Million EUR	-8.41%
2023 Q1	161.23 Million EUR	-8.88%
2023 Q4	223.04 Million EUR	-10.99%
2022 Q1	162.61 Million EUR	185.46%
2022 FY	805.68 Million EUR	35.39%
2022 Q4	176.94 Million USD	-12.14%
2022 Q3	201.38 Million EUR	-24.11%
2022 Q2	265.37 Million EUR	63.19%
2021 Q1	212.95 Million EUR	-15.38%
2021 Q3	56.96 Million EUR	-77.27%
2021 Q2	250.59 Million EUR	17.68%
2021 FY	595.06 Million EUR	-40.26%
2021 Q4	56.96 Million USD	0.0%
2020 Q3	322.78 Million EUR	117.92%
2020 FY	996.13 Million EUR	-11.95%
2020 Q1	273.57 Million EUR	-5.45%
2020 Q2	148.12 Million EUR	-45.86%
2020 Q4	251.64 Million EUR	-22.04%
2019 Q2	316.8 Million EUR	37.1%
2019 Q4	289.35 Million EUR	-1.62%
2019 FY	1.13 Billion EUR	13.81%
2019 Q1	231.08 Million EUR	4.51%
2019 Q3	294.12 Million EUR	-7.16%
2018 Q2	261.69 Million EUR	7.01%
2018 Q1	244.55 Million EUR	21.76%
2018 FY	994.12 Million EUR	-0.92%
2018 Q3	266.76 Million EUR	1.94%
2018 Q4	221.11 Million EUR	-17.11%
2017 FY	1 Billion EUR	6.81%
2017 Q4	200.84 Million EUR	-24.11%
2017 Q3	264.66 Million EUR	-7.18%
2017 Q2	285.12 Million EUR	12.83%
2017 Q1	252.71 Million EUR	2.2%
2016 Q1	231.45 Million EUR	-8.29%
2016 Q2	221.21 Million EUR	-4.42%
2016 Q3	239.47 Million EUR	8.25%
2016 FY	939.4 Million EUR	-3.19%
2016 Q4	247.26 Million EUR	3.25%
2015 Q3	247.32 Million EUR	5.54%
2015 Q1	236.36 Million EUR	4.37%
2015 FY	970.37 Million EUR	13.14%
2015 Q2	234.32 Million EUR	-0.86%
2015 Q4	252.36 Million EUR	2.04%
2014 Q4	226.46 Million EUR	5.88%
2014 FY	857.68 Million EUR	16.51%
2014 Q3	213.88 Million EUR	10.55%
2014 Q2	193.47 Million EUR	-13.58%
2014 Q1	223.86 Million EUR	31.93%
2013 Q4	169.69 Million EUR	-8.8%
2013 FY	736.12 Million EUR	11.52%
2013 Q1	187.4 Million EUR	25.25%
2013 Q2	192.95 Million EUR	2.96%
2013 Q3	186.06 Million EUR	-3.57%
2012 Q3	171.56 Million EUR	2.23%
2012 Q2	167.82 Million EUR	-1.9%
2012 Q1	171.07 Million EUR	79.25%
2012 FY	660.08 Million EUR	136.71%
2012 Q4	149.62 Million EUR	-12.79%
2011 Q3	114.69 Million EUR	598.82%
2011 Q4	95.43 Million EUR	-16.79%
2011 FY	278.86 Million EUR	32.99%
2011 Q1	52.31 Million EUR	28.87%
2011 Q2	16.41 Million EUR	-68.63%
2010 FY	209.68 Million EUR	-7.44%
2010 Q4	40.59 Million EUR	-5.52%
2010 Q3	42.96 Million EUR	0.0%
2009 FY	226.52 Million EUR	11.61%
2008 FY	202.96 Million EUR	38.68%
2007 FY	146.35 Million EUR	45.64%
2006 FY	100.49 Million EUR	36.56%
2005 FY	73.58 Million EUR	0.0%

Peer Operating Income Comparison of Grifols, S.A.

Name	Operating Income	Operating Income Difference
AstraZeneca PLC	8.19 Billion USD	90.243%
Bristol-Myers Squibb Company PFD CONV 2	17.24 Billion USD	95.364%
CSPC Pharmaceutical Group Limited	7.01 Billion USD	88.606%
Clarus Therapeutics Holdings, Inc.	-39.73 Million USD	2111.975%
Novartis AG	9.76 Billion USD	91.817%
PT Kalbe Farma Tbk.	3625.13 Billion USD	99.978%

Global Stocks Search

Grifols, S.A. (GIKLY)

Operating Income Summary of Grifols, S.A.

Annual Operating Income Chart of Grifols, S.A. (2023 - 2005)

Historical Annual Operating Income of Grifols, S.A. (2023 - 2005)

Peer Operating Income Comparison of Grifols, S.A.